Clinical Trial Update: Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients [NA]

View source ↗

Summary

Update on a head-to-head clinical trial comparing NovoRapid 30 Mix Injection FlexPen and Humalog 25 Mix Injection KwikPen in adults with Type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Humalog 25 Mix Injection KwikPen (insulin lispro protamine suspension and insulin lispro)
• NovoRapid 30 Mix Injection FlexPen (insulin aspart protamine suspension and insulin aspart)

Snippet

Sponsor: Nagaoka Red Cross Hospital | Conditions: Diabetes Complications, Diabetes Mellitus, Type 2 | NA | Status: UNKNOWN